Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
NewEdge Advisors, LLC's Holding History (CIK: 0001633516)
Note: Option positions (PUT/CALL) are excluded.
Q2 2023
Shares
217
Value ($000)
$2
Avg Close
$11.04
Range
$9.98 - $12.03
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2023
217
$2
$11.04
$9.98 - $12.03